health
STAT+: Prometheus raises $12 billion in capital for artificial engineers
Why this matters: health reporting relevant to everyday decisions and well-being.
Want to stay on top of the science and politics driving biotech today?&#x A0;Sign up&#x A0;to get our biotech newsletter in your inbox. AI continues to draw massive capital and new use cases in biopharma: Take Prometheus’ $12 billion raise to build “artificial general engineers,” or Abridge’s new partnerships with Eli Lilly and Nvidia, which aims in part to optimize the clinical trial recruitment process. Plus, a nonprofit buys a shelved drug for a pediatric leukemia with plans to distribute it for free.Continue to STAT+ to read the full story…
Article preview — originally published by STAT News. Full story at the source.
Read full story on STAT News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop